Webinar Date/Time: Session 1: Tues, Dec 5, 2024, at 12:00 PM BST | 1:00 PM CET Session 2: Tues, Dec 5, 2024, at 11:00 AM PST | 2:00 PM EST | 7:00 PM GMT Session 3: Wed, Dec 6, 2024, at 9:30 AM IST | 12:00 PM SGT | 1:00 PM JST | 3:00 PM AEDT
This webinar will focus on the sequence-specific method and provide a deep dive into the UV-spectrometric determination of the oligonucleotide melting temperature (Tm) using the Agilent Cary 3500 UV-Vis after a short introduction to oligonucleotides.
Register Free: https://www.spectroscopyonline.com/spec_w/advanced-analyticals
Event Overview:
In the pharmaceutical industry, all starting materials and the active pharmaceutical ingredients (APIs) of a drug product must be subjected to analytical identity (ID) testing as part of the release prior to their introduction into the pharmaceutical manufacturing process. For quality control laboratories in general—and particularly for a contract development and manufacturing organization (CDMO) handling a wide variety of materials—it is preferable to perform ID tests using a simple, fast, highly specific analytical method. This preference also applies to oligonucleotides, an emerging class of APIs, where a combined ID testing strategy should be applied, including intact mass determination and a sequence-specific method.
After a short introduction to oligonucleotides, this webinar will focus on the sequence-specific method and provide a deep dive into the UV-spectrometric determination of the oligonucleotide melting temperature (Tm) using the Agilent Cary 3500 UV-Vis.
Key Learning Objectives:
Who Should Attend:
Speakers:
Alexandra H. Heussner, PhD
Laboratory Manager
Analytical Science Laboratory
Vetter Pharma
Register Free: https://www.spectroscopyonline.com/spec_w/advanced-analyticals